ABSTRACT
INTRODUCTION
Hepatitis B virus (HBV) is endemic in Côte d'Ivoire [1] . Kra et al. showed in 2001 through a survey conducted by the systematic elimination of blood donors with risk factors for viral hepatitis B, the prevalence of HBs antigen (HBsAg) was 12.5% in blood donor transfusion center in Bouaké, Côte d'Ivoire [2] . Recently, Assi et al., reported in a study conducted in the general population Abidjanaise with a prevalence of 8% [3] . This high prevalence of HBsAg was associated with a low rate of HBV vaccinetion coverage, estimated at 2.9% [3] . Children from 0 -12 months have been routinely vaccinated since 2001 in Côte d'Ivoire as a part of the expanded program on immunization [4] . According to several authors, catching up vaccination targeted at risk populations is needed to reduce the prevalence of this virus [5] . The aim of our study was to evaluate through the blood donors, the prevalence of HBsAg in Abidjan in people without risk factors etrouvé viral hepatitis B as well as the factors favoring.
MATERIALS AND METHODS

Population
The blood transfusion center of the Cocody Teaching Hospital Center, one of four university hospitals in Côte d'Ivoire was inaugurated on 28 January 2010. It receives mainly from donors in Abidjan, agglomeration more than 5 million inhabitants.
Type of Study, Inclusion and Non-Inclusion
We have conducted a cross-sectional study of 28 January 2010 to 31 December 2010. All new applicants volunteer blood donation were recruited consecutively and prospectively. They all consistently responded to a standardized questionnaire seeking risk factors for viral hepatitis B: behavior at risk for hepatitis B virus (unprotected sex, multiple sexual partners, using or sharing of unsterilized * No conflict of interest. # Corresponding author. equipment), history of viral hepatitis (B or C) or sexually transmitted diseases, patients with the virus human immunodeficiency virus (HIV), sexually transmitted infection, a history of liver or blood transfusion, sexual partner or around viral hepatitis carrier B, C, HIV and syphilis. They all underwent a clinical examination (clinical abnormalities suggestive of liver disease or HIV or syphilis) and blood hemoglobin. A donor with a risk factor for viral hepatitis B or C, HIV or syphilis, pregnant, nursing, weight < 50 kg or hemoglobin < 11 g/dl was excluded from the study (and donation). All other blood donors were systematically collected for HBsAg, anti heaptitis C virus (HCV), syphilis serology and HIV status.
Serological
These blood samples were analyzed with an ELISA third generation (combined ELISA Murex ® Abbott). When the sample was positive, a second analysis was performed on the same sample with the same ELISA.
Statistical Analysis
Analysis of the results was performed with SPSS * (packing system for social science, Chicago Michigan USA version 17). The seroprevalence of HBsAg was expressed in percentage confidence interval 95% according to all donors and age, sex, blood group rhesus HIV status vis-à-vis the viral hepatitis C, syphilis and human immunodeficiency virus. The relationship between the existence of HBsAg and the factors studied (age, sex, serology hepatitis C virus, human immunodeficiency virus, syphilis and blood groups) has been studied in univariate analysis with Fisher's exact test (quantitative variables) or Chi Square test (qualitative variables). Multivariate analysis was performed by logistic regression. The relationship was significant when the confidence interval of the odds ratio was significantly different from 1 (significance p less than 5%).
Ethics
All donors were received by a medical center. They were informed of the tests performed, the significance of their positivity. Their consent was obtained before inclusion. They all received advice on all risky practices, the value of vaccination against viral hepatitis B in HIV-negative cases. The assurance was given to them that the data collected is anonymous. All donors received a written invitation to communicate the results of their serological tests. Those carrying markers for syphilis or HIV were assigned systematically to the anti sexually transmitted diseases, the Pasteur Institute of Cocody. Those carriers of HBsAg and/or anti viral hepatitis C are assigned hepatologists University Hospital of Cocody. Subjects not carrying the HBsAg unvaccinated were sensitized to vaccination against hepatitis B. Our study was consistent with the Universal Declaration of Helsinki of 2008.
RESULTS
We received 4310 blood donors excluded 487 (participation rate 88.7%, n = 3823). The age of 3823 blood donors ranged from 17 -46 years (mean 25.3 years, SD 4.8). There were 1303 women and 2790 men (sex ratio 2.17). Table 1 shows the demographic and serological blood donors HBsAg carriers. 
DISCUSSION
Prevalence of HbsAg
Our study shows that the prevalence of HBsAg among blood donors without risk factors for viral hepatitis B was 4.76%. This figure is lower than that reported in the blood transfusion center in Bouaké (12.5%) [2] and recently in the general population in Abidjan (8%) [3] . The main reason is the systematic elimination of blood donation, all donors with risk factors for hepatitis B in our sample. In the study in Bouaké, blood donors had a history of viral contagion B with 7% of cases of unprotected intercourse and 2.4% if more than 2 partners in the last six months [2] . The study Abidjanaise had not sought this history [3] . The demographic structure of our sample was comparable to the two studies cited with a male predominance (sex ratio 2.17) and a mean age of 25 years.
The prevalence of HBsAg in our study was also lower than that reported in the study Matee [6] and several others made in sub-Saharan Africa (Table 3 ) [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The difference is, in addition to the elimination of donors with risk factors for hepatitis B virus, the only character voluntary and free blood donation in Côte d'Ivoire. Several authors have shown that voluntary donors were less often compared with HBsAg positive donors paid or replacement donors [6, 12, 19, 20] . The existence of risk factors for hepatitis B is associated with a higher prevalence of HBsAg [6, 17] . However, our figure is in the proportions (2% -16%) reported in West Africa by Tagny et al. [21] . The prevalence of HBsAg in our study was higher than that reported in a recent study in Madagascar [22] , the Maghreb [23] [24] [25] or in other regions outside Africa [26, 27] , in connection with low endemicity of HBV in these regions.
This apparent contradiction between the absence of risk factors and B viral detection of HBsAg in blood donors in our study is mainly due to ignorance or forgetfulness of history of viral hepatitis B by respondents. Indeed, some patients may reflect a maternal-fetal transmission is a major source of contamination in sub-Saharan Africa [18, 28] . Second, given the retrospective nature of the viral contagion Research B, respondents may have forgotten many risk situations experienced B virus. For instance during childhood, intramuscular injections for malaria in childhood with unsterilised material, vaccination chain with reusable devices vaccination before the era of materiovigilance, transfusion for anemia of malaria. Some people can not voluntarily mention unprotected sex, extramarital relationships, addiction. It may also include one or intrafamilial transmission of index cases not knowing his HIV status or viral B.
The practical consequence is that it is not appropriate to conduct a vaccination against viral hepatitis B without individual serological screening for hepatitis B in a subject not even after a population at high risk for viral hepatitis B (no risk factors found viral B) the risk of vaccinating a subject already carrying HBsAg.
Risk Factors for the Presence of HbsAg
Our study also shows that age and male gender are independent risk factors for viral hepatitis B in people with no history of viral contagion B.
Age is recognized as a risk factor B virus in several studies, however, the age of these studies varied choice. And some like ours the age of 30 years were most at risk [6, 9, 18] . For others it may concerned rather younger subjects (under 30 years) without a clear explanation have been established [11, 14, 20] .
The male is a recognized independent risk factor for carriage of HBsAg in individuals with or without risk factors for viral B [6, 14, 24] .
Subjects without risk factors found HVB with positive syphilis serology had significantly more (odds ratio 14) co infection HBV. This is a common condition in black Africa and sharing sexual transmission, blood and vertically with the hepatitis B [6] . This association was also found among blood donors in Tanzania [6] and Nigeria [11] .
The blood group is not a risk factor for carriage of HBsAg in our study although lower in the blood group B and higher in blood group O. This difference was also observed in other studies correlated with the proportion of blood groups in the populations studied. However, none has demonstrated a link between blood groups and viral hepatitis B or C [23, 29, 30] .
CONCLUSIONS
The prevalence of HBsAg (4.76%) among those without risk factors for hepatitis B virus found although lower than that reported in the population in Abidjan, was not negligible.
Because of the prevalence, our study provides no argument for vaccination policy based solely on at-risk B virus populations in our endemic area viral B. It is essential to detect individual viral hepatitis B before vaccination against viral hepatitis B in adults.
